Compounded Tirzepatide (GLP-1/GIP)
US$ 28.25
retatrutide weight loss clinical data π may be redefining obesity treatment. New from TRIUMPH-1 Trial showed: π₯ ~28% average over 80 weeks π₯ >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide vs Tirzepatide vs Semaglutide
Description
Serious side effects were rare and occurred in 0 to 6 percent of subjects
Identification of novel therapeutic targets
While still more pronounced than pre weight loss, my nasolabial folds were definitely not as deep, while my jawline looked in better nick too
Consistent moderate deficits produce better long-term outcomes than alternating between very low intake and compensatory eating
At month 3, I got a DEXA scan showing Id already lost 6 pounds of muscle along with 18 pounds of fat
